Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches

Saved in:
Bibliographic Details
Main Authors: Clement Meseko, Melvin Sanicas, Yash Gupta, Binod Kumar
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-10-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1497018/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850184783635677184
author Clement Meseko
Melvin Sanicas
Yash Gupta
Binod Kumar
author_facet Clement Meseko
Melvin Sanicas
Yash Gupta
Binod Kumar
author_sort Clement Meseko
collection DOAJ
format Article
id doaj-art-e09612daaa0b426caa5b9ecce365beb2
institution OA Journals
issn 2235-2988
language English
publishDate 2024-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-e09612daaa0b426caa5b9ecce365beb22025-08-20T02:16:56ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882024-10-011410.3389/fcimb.2024.14970181497018Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approachesClement Meseko0Melvin Sanicas1Yash Gupta2Binod Kumar3Regional Centre for Animal Influenza, National Veterinary Research Institute, Vom, NigeriaMedical and Clinical Development, Clover Biopharmaceuticals, Boston, MA, United StatesDepartment of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA, United StatesDepartment of Antiviral Research, Institute of Advanced Virology, Thiruvananthapuram, Kerala, Indiahttps://www.frontiersin.org/articles/10.3389/fcimb.2024.1497018/fullcoronavirusSARS-CoV2COVID-19influenza virusherpesviruscellular signaling
spellingShingle Clement Meseko
Melvin Sanicas
Yash Gupta
Binod Kumar
Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches
Frontiers in Cellular and Infection Microbiology
coronavirus
SARS-CoV2
COVID-19
influenza virus
herpesvirus
cellular signaling
title Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches
title_full Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches
title_fullStr Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches
title_full_unstemmed Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches
title_short Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches
title_sort editorial antiviral options for emerging and reemerging viral diseases current therapeutics novel drug candidates and new approaches
topic coronavirus
SARS-CoV2
COVID-19
influenza virus
herpesvirus
cellular signaling
url https://www.frontiersin.org/articles/10.3389/fcimb.2024.1497018/full
work_keys_str_mv AT clementmeseko editorialantiviraloptionsforemergingandreemergingviraldiseasescurrenttherapeuticsnoveldrugcandidatesandnewapproaches
AT melvinsanicas editorialantiviraloptionsforemergingandreemergingviraldiseasescurrenttherapeuticsnoveldrugcandidatesandnewapproaches
AT yashgupta editorialantiviraloptionsforemergingandreemergingviraldiseasescurrenttherapeuticsnoveldrugcandidatesandnewapproaches
AT binodkumar editorialantiviraloptionsforemergingandreemergingviraldiseasescurrenttherapeuticsnoveldrugcandidatesandnewapproaches